Testing effectiveness (Phase 2)Not Yet RecruitingNCT07699237
What this trial is testing
Phase II Trial to Evaluate Rechallenge With Platinum-based Chemotherapy (Carboplatin, Etoposide) for Progression During Tarlatamab Therapy in Relapsed Extensive Disease Small-cell Lung Cancer (SCLC)
Who this might be right for
Extensive Disease Small Cell Lung Cancer
University of Cologne 54